CAIRO (Reuters) - Egyptians decide on Saturday on a constitution promoted by its Islamist backers as the way out of a prolonged political crisis and rejected by opponents as a recipe for further divisions in the Arab world's biggest nation.
Voting begins in a referendum on a divisive draft basic law that has pitted Islamist supporters of President Mohamed Mursi against a liberal, secular and Christian opposition in often bloody clashes in Cairo and other cities.
The opposition says the constitution is too Islamist and tramples on minority rights. Mursi's supporters say the charter is needed if progress is to be made towards democracy nearly two years after the fall of military strongman Hosni Mubarak.
In Alexandria on Friday, tensions boiled over into a street brawl between rival factions armed with clubs, knives and swords. Several cars were set on fire and a Muslim preacher who had urged people to vote "yes" to the constitution was trapped inside his mosque by angry opposition supporters.
In the capital, Cairo, both sides made low-key final efforts to rally supporters.
Flag-waving Islamists gathered peacefully at one of the main mosques, some shouting "Islam, Islam" and "We've come here to say 'yes' to the constitution".
Opposition supporters - who have been urged to vote "no" by their leaders - assembled outside the presidential palace.
The building remains ringed with police, soldiers and tanks after street clashes caused at least eight deaths earlier this month in violence prompted by Mursi's decision to award himself sweeping powers in order to ram through the new charter.
As darkness fell, there appeared to be more bystanders and street vendors present than opposition demonstrators. A woman addressed the crowd through a loudhailer, shouting obscenities about Mursi, but many in her audience seemed more interested in drinking tea or having their picture taken in front of a tank.
"I don't like Mursi," said Moustafa Ahmed, 25, a teacher. "But I haven't decided what to vote for tomorrow so I decided to come here to listen to the protesters and chat to them one last time."
TWO DAYS OF VOTING
The referendum will be held on two days - this Saturday and next - because there are not enough judges willing to monitor all polling stations after some in the judiciary said they would boycott the vote.
Egyptians are being asked to accept or reject a constitution that must be in place before a parliamentary election can be held next year - an event many hope can steer the country towards stability.
The measure is generally expected to pass, given the well-organized Muslim Brotherhood's record of winning elections since the fall of Mubarak. Many Egyptians, tired of turmoil, may simply fall in line and vote "yes".
If the constitution is voted down, a new assembly will have to be formed to draft a revised version, a process that could take up to nine months.
Just over half of Egypt's electorate of 51 million will vote in the first round in Cairo and other cities. Polling stations open at 8 a.m. (0600 GMT) and close 12 hours later.
Official results will not be announced until after the second round, though it is likely that details will emerge after the first round that will give an idea of the overall trend.
To provide security for the vote, the army has deployed about 120,000 troops and 6,000 tanks and armored vehicles to protect polling stations and other government buildings
While the military backed Mubarak and his predecessors, it has not intervened on either side in the present crisis.
The charter has been criticized by some overseas bodies.
The International Council of Jurists, a Geneva-based human rights group, said it falls short of international standards on the accountability of the armed forces, the independence of the judiciary, and recognition of human rights.
United Nations human rights experts said the draft should be reviewed to ensure that Egypt meets its obligations under international law on equality and women's rights.
(Additional reporting by Ahmed Fahm and Abdel Rahman Youssef in Alexandria; Writing by Giles Elgood; Editing by Alastair Macdonald)
Uterine cancer is one of the most deadly cancers, which actually starts in the lining of cells in the uterus. The uterus or womb is a vital part of a woman?s reproductive system.
Type of uterine cancer
That cancer can indicate various types of cancers that occur in a woman?s uterus. Uterine Sarcoma, commonly known as leiomyosarcomas is a type of uterine cancer, which occurs in muscle layer of a uterus. Endometrial cancer is another type of uterine cancer, which originates from the cells that are found in glands of the uterine lining or endometrium. Cervical cancer is a different type of uterine cancer, it is known that arise from the lower part of the uterus. It extends the transition region of a woman?s cervix and connecting to the upper part of the vagina.
Symptoms
A woman with uterine cancer may notice some common symptoms. However, they can vary from person to person depending on the disease under consideration. The common symptoms include painful or difficult urination, unusual vaginal discharge or bleeding, extreme pain during sexual intercourse, a weight loss typical pelvic lump, abnormal, pain in the pelvic region and having never nursed. In fact, uterine cancer rarely occurs before menopause, when a woman having regular menstrual periods.
Generally occurs during the period when the regular menstruation cycle stops. If a woman sees resurgence of bleeding at this stage of her life, she should immediately bring to the attention of his general physician, as there may be a possibility of uterine cancer.
The most common symptom of uterine cancer is abnormal bleeding from the uterus of a woman after menopause. The bleeding can be in the form of a blood streaked, watery discharge containing more blood. In some cases, a woman may experience lower abdominal pain too.
Causes
There are several causes of uterine cancer, which have been discovered till date. Diabetes, obesity, polycystic ovary ovary having prolonged Anovulation, parity or having to load a single child, lack of menstruation, extended use of tamoxifen to treat breast cancer and estrogen intake without opposition without progestin are some of the causes of uterine cancer.
Disease diagnosis
Cancer can be diagnosed by endometrial and endocervical sampling. In addition to these techniques, the vaginal ultrasound is also used to detect endometrial thickness thicker because of the uterus can result in some serious change cancerous. In addition to this, the Pap test can also be an accurate detection of uterine cancer, but it cannot be defined as a reliable source.
Treatment
The treatment of this cancer is performed on the basis of the grade and stage of the cancer. Abdominal hysterectomy is a standard therapy, which involves the surgical removal of the uterus of the woman with the ovaries and fallopian tubes, flushing of the abdominal cavity to determine the malignant cells and selective removal of the pelvic and aortic lymph nodes. Many doctors prefer the use of hormone therapy that removes the possibility of metastatic cancer. Once again, women also opt for radiation therapy for the treatment of uterine cancer.
Although the treatment is a possibility for uterine cancer, yet you should take immediate action after noticing symptoms. Do not let them reach a level which cannot be cured!
A love that never tasted so good. A brother protecting the one he loves. An evil king ready to meet his doom. She never knew what she was getting into when he bit her and left his mark...for good.
Owner:
Game Masters:
This topic is an Out Of Character part of the roleplay, ?Midnight Tease?. Anything posted here will also show up there.
Topic Tags:
Forum for completely Out of Character (OOC) discussion, based around whatever is happening In Character (IC). Discuss plans, storylines, and events; Recruit for your roleplaying game, or find a GM for your playergroup.
Here ya reserve yer characters... :)
Nami L'Chi
Member for 0 years
Post a reply
RolePlayGateway is a site built by a couple roleplayers who wanted to give a little something back to the roleplay community. The site has no intention of earning any profit, and is paid for out of their own pockets.
If you appreciate what they do, feel free to donate your spare change to help feed them on the weekends. After selecting the amount you want to donate from the menu, you can continue by clicking on PayPal logo.
Here's the weirdest story you've heard all day: Justin Bieber was the target of an imprisoned man's plot to murder and then castrate the Canadian pop star and his bodyguard. The plan was reportedly so serious that two other criminals were sent out on a mission to kill Bieber, though they fortunately were caught before anything could happen to the 18-year-old.
BELGRADE, Serbia (AP) ? A judge has ordered Serbia's richest man to spend 30 days in prison pending trial after his arrest on suspicion of corruption.
Billionaire retail tycoon Miroslav Miskovic, one of the Balkan country's most influential figures, was arrested along with his son Marko and eight others, in connection with the privatization of several Serbian road construction companies in 2005, during which the suspects allegedly gained illegal profits of about ?30 million ($39 million).
Miskovic, his son and four others were handed 30 days in jail on Friday. The rest were freed pending trial.
The arrest was part of an anti-corruption sweep launched by Serbia's new nationalist-led government. Critics say the campaign has mostly been aimed at political opponents.
Serbia must fight widespread graft to fulfill its goal of joining the EU.
LSUHSC's Weiss chosen to help set national eye policy, researchPublic release date: 13-Dec-2012 [ | E-mail | Share ]
Contact: Leslie Capo lcapo@lsuhsc.edu 504-568-4806 Louisiana State University Health Sciences Center
New Orleans, LA Kathleen Sebelius, Secretary of the United States Department of Health and Human Services, has invited Jayne S. Weiss, MD, Professor and Chair of the Department of Ophthalmology, Herbert E. Kaufman, MD Endowed Chair in Ophthalmology, and Director of LSU Eye Center of Excellence at LSU Health Sciences Center New Orleans, to serve on the National Advisory Eye Council. Effective immediately, she will serve a four-year term. Dr. Weiss is among the 12 members chosen in the United States, and the only member from Louisiana.
According to the National Eye Institute (one of the institutes of the National Institutes of Health), the Council advises, assists, consults with, and makes recommendations to the Secretary of Health and Human Services and the Director of the National Eye Institute (NEI) on matters related to the activities carried out by and through the NEI and the policies respecting these activities. The Council may review applications for grants and cooperative agreements for research and training and recommend approval of applications for projects which show promise of making valuable contributions to human knowledge; may review any grant, contract, or cooperative agreement proposed to be made or entered into by the Institute; may collect, by correspondence or by personal investigation, information as to studies which are being carried on in the United States or any other country and, with the approval of the Director of NEI, make available such information through appropriate publications for the benefit of public and private health entities, health professions personnel and scientists, and for the information of the general public.
A native of New York City, New York, Dr. Weiss graduated from State University of Buffalo summa cum laude with a 4.0 average and was elected to Phi Beta Kappa. She received her Doctor of Medicine degree from Mt. Sinai Medical School in 1979 and was elected to Alpha Omega Alpha, the medical honor society. She completed her residency training in ophthalmology at the Bascom Palmer Eye Institute, University of Miami School of Medicine in 1983 followed by a fellowship in ocular pathology at Massachusetts Eye and Ear Infirmary, Harvard Medical School in Boston and a fellowship in cornea and external eye diseases at Emory University in Atlanta.
Dr. Weiss was Visiting Professor at Tri Service General Hospital in Taipei, Taiwan in 1985 and Fulbright Professor at Godfrey Huggins School of Medicine in Harare Zimbabwe in 1986. She subsequently served as Assistant Professor and Associate Professor in the Department of Ophthalmology at University of Massachusetts Medical Center from 1986 to 1995. She joined Kresge Eye Institute, the Department of Ophthalmology at Wayne State University in 1995 and left in 2011 as Professor of Ophthalmology and Pathology, and Director of Refractive Surgery, when LSU Health Sciences Center New Orleans recruited her.
Dr. Weiss' principal clinical and research interests are corneal and external diseases, refractive surgery, and corneal dystrophies. Her interest in Schnyder's dystrophy spans 18 years during which time she has studied the clinical findings, visual prognosis and discovered the causative gene for this disease.
Dr. Weiss was Chair of the FDA Ophthalmic Devices Panel, Chair of the American Academy of Ophthalmology Basic and Clinical Sciences Courses (13 books) ,Chair of the American Academy of Ophthalmology Basic and Clinic Sciences Course on Refractive Surgery and edited its first book on Refractive Surgery and Scientific Program Director of the Eye Bank Association of America. She was Acting Chair for the April 2008 FDA meeting on LASIK.
She has been a member of the Basic and Clinical Sciences Course on Cornea and External Eye Diseases, member of NIH Visual Sciences Study Section, Eye Bank Association Research Committee, Preferred Practice Plan for Cornea and External Eye Diseases and the Eye Bank Committee of the American Academy of Ophthalmology, member of the Board of Directors of the Cornea Society and member of the Medical Advisory Board of the Eye Bank Association of America.
Dr. Weiss has received the Service Advisory Award from the FDA and two Secretariat Awards from the American Academy of Ophthalmology. She presently is Chair of the International Committee for Classification of the Corneal Dystrophies, consultant to the FDA Ophthalmic Devices Panel, and a member of the editorial boards of Cornea journal. She has authored 90 articles and chapters.
###
LSU Health Sciences Center New Orleans educates Louisiana's health care professionals. The state's academic health leader, LSUHSC comprises a School of Medicine, the state's only School of Dentistry, Louisiana's only public School of Public Health, and Schools of Allied Health Professions, Nursing, and Graduate Studies. LSUHSC faculty take care of patients in public and private hospitals and clinics throughout the region. In the vanguard of biosciences research in a number of areas in a worldwide arena, the LSUHSC research enterprise generates jobs and enormous economic impact. LSUHSC faculty have made lifesaving discoveries and continue to work to prevent, advance treatment, or cure disease. To learn more, visit http://www.lsuhsc.edu and http://www.twitter.com/LSUHSCHealth.
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
LSUHSC's Weiss chosen to help set national eye policy, researchPublic release date: 13-Dec-2012 [ | E-mail | Share ]
Contact: Leslie Capo lcapo@lsuhsc.edu 504-568-4806 Louisiana State University Health Sciences Center
New Orleans, LA Kathleen Sebelius, Secretary of the United States Department of Health and Human Services, has invited Jayne S. Weiss, MD, Professor and Chair of the Department of Ophthalmology, Herbert E. Kaufman, MD Endowed Chair in Ophthalmology, and Director of LSU Eye Center of Excellence at LSU Health Sciences Center New Orleans, to serve on the National Advisory Eye Council. Effective immediately, she will serve a four-year term. Dr. Weiss is among the 12 members chosen in the United States, and the only member from Louisiana.
According to the National Eye Institute (one of the institutes of the National Institutes of Health), the Council advises, assists, consults with, and makes recommendations to the Secretary of Health and Human Services and the Director of the National Eye Institute (NEI) on matters related to the activities carried out by and through the NEI and the policies respecting these activities. The Council may review applications for grants and cooperative agreements for research and training and recommend approval of applications for projects which show promise of making valuable contributions to human knowledge; may review any grant, contract, or cooperative agreement proposed to be made or entered into by the Institute; may collect, by correspondence or by personal investigation, information as to studies which are being carried on in the United States or any other country and, with the approval of the Director of NEI, make available such information through appropriate publications for the benefit of public and private health entities, health professions personnel and scientists, and for the information of the general public.
A native of New York City, New York, Dr. Weiss graduated from State University of Buffalo summa cum laude with a 4.0 average and was elected to Phi Beta Kappa. She received her Doctor of Medicine degree from Mt. Sinai Medical School in 1979 and was elected to Alpha Omega Alpha, the medical honor society. She completed her residency training in ophthalmology at the Bascom Palmer Eye Institute, University of Miami School of Medicine in 1983 followed by a fellowship in ocular pathology at Massachusetts Eye and Ear Infirmary, Harvard Medical School in Boston and a fellowship in cornea and external eye diseases at Emory University in Atlanta.
Dr. Weiss was Visiting Professor at Tri Service General Hospital in Taipei, Taiwan in 1985 and Fulbright Professor at Godfrey Huggins School of Medicine in Harare Zimbabwe in 1986. She subsequently served as Assistant Professor and Associate Professor in the Department of Ophthalmology at University of Massachusetts Medical Center from 1986 to 1995. She joined Kresge Eye Institute, the Department of Ophthalmology at Wayne State University in 1995 and left in 2011 as Professor of Ophthalmology and Pathology, and Director of Refractive Surgery, when LSU Health Sciences Center New Orleans recruited her.
Dr. Weiss' principal clinical and research interests are corneal and external diseases, refractive surgery, and corneal dystrophies. Her interest in Schnyder's dystrophy spans 18 years during which time she has studied the clinical findings, visual prognosis and discovered the causative gene for this disease.
Dr. Weiss was Chair of the FDA Ophthalmic Devices Panel, Chair of the American Academy of Ophthalmology Basic and Clinical Sciences Courses (13 books) ,Chair of the American Academy of Ophthalmology Basic and Clinic Sciences Course on Refractive Surgery and edited its first book on Refractive Surgery and Scientific Program Director of the Eye Bank Association of America. She was Acting Chair for the April 2008 FDA meeting on LASIK.
She has been a member of the Basic and Clinical Sciences Course on Cornea and External Eye Diseases, member of NIH Visual Sciences Study Section, Eye Bank Association Research Committee, Preferred Practice Plan for Cornea and External Eye Diseases and the Eye Bank Committee of the American Academy of Ophthalmology, member of the Board of Directors of the Cornea Society and member of the Medical Advisory Board of the Eye Bank Association of America.
Dr. Weiss has received the Service Advisory Award from the FDA and two Secretariat Awards from the American Academy of Ophthalmology. She presently is Chair of the International Committee for Classification of the Corneal Dystrophies, consultant to the FDA Ophthalmic Devices Panel, and a member of the editorial boards of Cornea journal. She has authored 90 articles and chapters.
###
LSU Health Sciences Center New Orleans educates Louisiana's health care professionals. The state's academic health leader, LSUHSC comprises a School of Medicine, the state's only School of Dentistry, Louisiana's only public School of Public Health, and Schools of Allied Health Professions, Nursing, and Graduate Studies. LSUHSC faculty take care of patients in public and private hospitals and clinics throughout the region. In the vanguard of biosciences research in a number of areas in a worldwide arena, the LSUHSC research enterprise generates jobs and enormous economic impact. LSUHSC faculty have made lifesaving discoveries and continue to work to prevent, advance treatment, or cure disease. To learn more, visit http://www.lsuhsc.edu and http://www.twitter.com/LSUHSCHealth.
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Keeping map data relevant's a full-time job -- just ask Nokia, Google and, yes, even Apple. Which is why Microsoft may be gearing up to offload some of that heavy lifting to users in the augmented reality guise of mobile gaming. Or at least that's one possible future outlined by a recently surfaced patent application. The USPTO doc, filed back in June of 2011, clearly lays out a crowdsourced "data collection system" whereby users sent on virtual missions to specific real-world targets would aid in the gathering of up-to-date geo-location data. With its thriving Xbox gaming arm and reinvigorated inroads into the mobile space, it wouldn't be much of a stretch for Microsoft to leverage a bit of corporate synergy to make its own mapping service more accurate, or simply license the data. Whatever the case may be, it's all up in legal limbo for the time being. So, for now, you'll have to content yourselves with AR missions of the Ingress kind.
![[ Back to EurekAlert! ]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_s8-K-mAL92mM_A4w6boHUvGBAIPaVRfqMIkQuTw2jKLWpIEzarrwfLJLeakBlC-LRUreAogN7yqTZ-Kkq8zb4f1v-Oc-sBhc2LQY9574E=s0-d){kind=small}
Public release date: 13-Dec-2012
Share ] 
